Clinical Trial Update: Gene Therapy for X-linked Severe Combined Immunodeficiency [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of Phase 1/2 testing for a gene therapy treatment for X-linked severe combined immunodeficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• X-linked Severe Combined Immunodeficiency

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: X-linked Severe Combined Immunodeficiency | Phase 1, Phase 2 | Status: COMPLETED